ITIH5 has been identified as an epigenetically silenced (class II) tumor suppressor gene (which we abbreviate as C2TSG [17]) in breast cancer [18] and multiple other tumor entities—for example, bladder [19] and colon cancer. This evidence concerns the gene ITIH5 and breast carcinoma.